Atara Biotherapeutics Strengthens Board And Senior Management Team

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has strengthened its board of directors and executive team by appointing Matthew K. Fust as a director and hiring Mitchall G. Clark, B.Pharm, as chief regulatory and quality assurance officer.

Help employers find you! Check out all the jobs and post your resume.

Back to news